Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

被引:16
|
作者
Saghari, Mohsen [1 ]
Gholamrezanezhad, Ali [1 ]
Mirpour, Sahar [1 ]
Eftekhari, Mohammad [1 ]
Takavar, Abbas [1 ]
Fard-Esfahani, Armaghan [1 ]
Fallahi, Babak [1 ]
Beiki, Davood [1 ]
机构
[1] Univ Tehran, Res Inst Nucl Med, Tehran 14114, Iran
关键词
differentiated thyroid carcinoma; thyroglobulin; whole-body scanning;
D O I
10.1097/00006231-200607000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result - increased thyroglobulin with negative WBS - is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results. Method We studied 32 differentiated thyroid carcinoma patients with elevated thyroglobulin level and negative WBS who had been treated with high-dose radioiodine. With a mean follow-up of 25.6 months (all follow-ups > 11 months), thyroglobulin and thyroid-stimulating hormone levels, WBS, clinical, radiographic and pathological findings following treatment were recorded. Results The mean pre-therapy off-treatment thyroglobulin was 152 +/- 119.0 ng (.) ml(-1). Although there was a mild trend towards an increase in thyroglobulin in the first post-treatment year, the difference was not significant. At the end of the follow-ups, 22 patients (68.7%) were categorized as non-responders to radioiodine therapy (any change or elevation of thyroglobulin or radiological and pathological evidences of progression), four patients (12.5%) as partial responders (transient reduction but not a normalization of thyroglobulin) and six patients (18.7%) as responders (normalization of thyroglobulin with no evidence of remnant disease). In nine of 10 partial and complete responders, reduction or normalization of thyroglobulin had occurred in the first post-treatment year. Conclusion We recommend that in differentiated thyroid carcinoma patients with elevated thyroglobulin and negative WBS, at least one course of radioiodine therapy should be undertaken and if reduction or normalization of serum thyroglobulin is not achieved, repeated courses of radioiodine therapy are not logical and other therapeutic methods should be applied.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [21] The reliability of thyroglobulin assay in comparison to therapeutic iodine-131 whole-body scan in the follow-up of patients with differentiated thyroid carcinoma
    Luo, QY
    Chen, LB
    Yu, YL
    Lu, HK
    Zhu, RS
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S207 - S207
  • [22] Diagnostic value of [99mTc]Tc-HYNIC-TOC scintigraphy in the management of differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan
    Esmatinia, Mohammad
    Askari, Emran
    Aghaee, Atena
    Jahanpanah, Parinaz
    Ayati, Narjess
    Shafiei, Susan
    Aryana, Kamran
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2022, 30 (02): : 122 - 128
  • [23] There is a significant incidence of whole body scan positive, thyroglobulin negative cases after initial radioiodine ablation in patients with well differentiated thyroid carcinoma.
    Karam, M
    Feustel, PJ
    Gianoukakis, AG
    Postal, ES
    Cheema, A
    Cooper, JA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 42P - 42P
  • [24] Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
    Ansari, M.
    Babaei, A. A.
    Shafiei, B.
    Javadi, H.
    Assadi, M.
    Nabipour, I.
    Asli, I. N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (13) : 1925 - 1929
  • [25] High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy
    Mariana Yoshii Tramontin
    Gabriela Maia Nobre
    Marcia Lopes
    Michel Pontes Carneiro
    Paulo Alonso Garcia Alves
    Fernanda Accioly de Andrade
    Fernanda Vaisman
    Rossana Corbo
    Daniel Bulzico
    Endocrine, 2021, 73 : 398 - 406
  • [26] High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy
    Tramontin, Mariana Yoshii
    Nobre, Gabriela Maia
    Lopes, Marcia
    Carneiro, Michel Pontes
    Alves, Paulo Alonso Garcia
    de Andrade, Fernanda Accioly
    Vaisman, Fernanda
    Corbo, Rossana
    Bulzico, Daniel
    ENDOCRINE, 2021, 73 (02) : 398 - 406
  • [27] Efficacy of empirical radioiodine therapy in patients with differentiated thyroid cancer and elevated serum thyroglobulin without evidence of structural disease
    Piscopo, L.
    Zampella, E.
    Nappi, C.
    Volpe, F.
    Gaudieri, V.
    Bianco, D.
    Volpicelli, F.
    Falzarano, M.
    Pace, L.
    Cuocolo, A.
    Klain, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S670 - S670
  • [28] Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer
    Kloos, Richard T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05): : 1519 - 1525
  • [29] Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma
    Franceschi, M
    Kusic, Z
    Franceschi, D
    Lukinac, L
    Roncevic, S
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (03) : 446 - 451
  • [30] Prognostic Significance of FDG PET/CT on the Follow-up of Patients of Differentiated Thyroid Carcinoma With Negative I131 Whole-Body Scan and Elevated Thyroglobulin Levels
    Caobelli, Federico
    Pizzocaro, Claudio
    Guerra, Ugo Paolo
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) : 196 - 196